• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与卵巢癌风险。对15项队列研究的系统评价和荟萃分析。

Diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies.

作者信息

Zhang Dongyu, Li Nan, Xi Yuzhi, Zhao Yuan, Wang Tengteng

机构信息

Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.

Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA.

出版信息

Diabetes Res Clin Pract. 2017 Aug;130:43-52. doi: 10.1016/j.diabres.2017.04.005. Epub 2017 Apr 13.

DOI:10.1016/j.diabres.2017.04.005
PMID:28554142
Abstract

AIM

Diabetes mellitus (DM) is hypothesized to be associated with an increased risk of ovarian cancer (OC), but current evidences are inconsistent. We aimed to further study this association.

METHODS

PubMed, EMBASE, Web of Science, and Scopus were searched for eligible articles. After descriptive summary of the data, a random-effects model was applied in quantitative synthesis. Subgroup analysis was performed by study locales and settings, and sensitivity analysis was conducted based on restrictive selection criteria. Funnel plots and the Egger's test were used to assess publication bias. Statistical heterogeneity in meta-analysis was assessed by the P value derived from the Cochrane Q statistic and I-squared value.

RESULTS

Fourteen articles involving data of 15 cohort studies were included for our research. Overall, 17 risk ratios (RRs) were synthesized and yielded a pooled RR of 1.32 (95%CI: 1.14-1.52, P<0.001, I=79.8%). Thirteen RRs were synthesized for type 2DM, and the pooled RR was 1.24 (95%CI: 1.06-1.44, P<0.001, I=81.8%). Four RRs were synthesized for type 1DM, and the result was significant (RR: 1.83, 95%CI: 1.21-2.78, P=0.080, I=55.7%). Results of sensitivity analysis suggested the robustness of a positive association between DM and OC risk, and subgroup analysis demonstrated that the association between DM and OC was much more substantial among Asia population. No publication bias was identified in meta-analysis.

CONCLUSION

Our study suggests there is a moderate relative increase in the risk of OC among DM patients. Future studies should investigate the effect of duration of DM and anti-diabetes intervention to OC risk.

摘要

目的

有假说认为糖尿病(DM)与卵巢癌(OC)风险增加有关,但目前的证据并不一致。我们旨在进一步研究这种关联。

方法

检索了PubMed、EMBASE、Web of Science和Scopus数据库中的相关文章。在对数据进行描述性总结后,采用随机效应模型进行定量合成。按研究地点和环境进行亚组分析,并根据严格的选择标准进行敏感性分析。采用漏斗图和Egger检验评估发表偏倚。通过Cochrane Q统计量得出的P值和I²值评估荟萃分析中的统计学异质性。

结果

本研究纳入了14篇文章,涉及15项队列研究的数据。总体而言,共合成了17个风险比(RRs),合并RR为1.32(95%CI:1.14 - 1.52,P < 0.001,I = 79.8%)。对2型糖尿病合成了13个RRs,合并RR为1.24(95%CI:1.06 - 1.44,P < 0.001,I = 81.8%)。对1型糖尿病合成了4个RRs,结果具有统计学意义(RR:1.83,95%CI:1.21 - 2.78,P = 0.080,I = 55.7%)。敏感性分析结果表明DM与OC风险之间存在正相关关系,且该关系具有稳健性,亚组分析表明DM与OC之间的关联在亚洲人群中更为显著。荟萃分析未发现发表偏倚。

结论

我们的研究表明,DM患者发生OC的风险有适度的相对增加。未来的研究应调查DM病程和抗糖尿病干预对OC风险的影响。

相似文献

1
Diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies.糖尿病与卵巢癌风险。对15项队列研究的系统评价和荟萃分析。
Diabetes Res Clin Pract. 2017 Aug;130:43-52. doi: 10.1016/j.diabres.2017.04.005. Epub 2017 Apr 13.
2
Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies.糖尿病与卵巢癌患者的长期死亡率。对12项队列研究的系统评价和荟萃分析。
Diabetes Metab Res Rev. 2017 May;33(4). doi: 10.1002/dmrr.2868. Epub 2016 Dec 6.
3
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Nov 26;11(11):CD013307. doi: 10.1002/14651858.CD013307.pub3.
4
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013307. doi: 10.1002/14651858.CD013307.pub2.
5
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
8
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
9
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
10
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.

引用本文的文献

1
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.通过药物重新定位革新卵巢癌治疗,实现加速且具成本效益的治疗。
Front Oncol. 2025 Jan 14;14:1514120. doi: 10.3389/fonc.2024.1514120. eCollection 2024.
2
Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019.1990年至2019年中国女性癌症疾病负担及危险因素趋势
Int J Public Health. 2024 Dec 4;69:1607245. doi: 10.3389/ijph.2024.1607245. eCollection 2024.
3
Prospective Analysis of Circulating Biomarkers and Ovarian Cancer Risk in the UK Biobank.
英国生物库中循环生物标志物与卵巢癌风险的前瞻性分析。
Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1347-1355. doi: 10.1158/1055-9965.EPI-24-0319.
4
Adherence to diabetes risk reduction diet and the risk of head and neck cancer: a prospective study of 101,755 American adults.坚持降低糖尿病风险饮食与头颈癌风险:对101755名美国成年人的前瞻性研究。
Front Nutr. 2023 Sep 22;10:1218632. doi: 10.3389/fnut.2023.1218632. eCollection 2023.
5
Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis.糖尿病与卵巢癌:风险因素、分子机制及对预后的影响。
Endocrine. 2024 Jan;83(1):1-9. doi: 10.1007/s12020-023-03477-6. Epub 2023 Aug 8.
6
Systematic analysis and prediction for disease burden of ovarian cancer attributable to hyperglycemia: a comparative study between China and the world from 1990 to 2019.高血糖所致卵巢癌疾病负担的系统分析与预测:1990年至2019年中国与世界的比较研究
Front Med (Lausanne). 2023 Apr 13;10:1145487. doi: 10.3389/fmed.2023.1145487. eCollection 2023.
7
Diabetes and anti-diabetic interventions and the risk of gynaecological and obstetric morbidity: an umbrella review of the literature.糖尿病及抗糖尿病干预措施与妇科及产科发病率风险:文献伞式评价。
BMC Med. 2023 Apr 18;21(1):152. doi: 10.1186/s12916-023-02758-1.
8
Burden of ovarian cancer in China from 1990 to 2030: A systematic analysis and comparison with the global level.中国卵巢癌负担:1990-2030 年的系统分析及与全球水平的比较
Front Public Health. 2023 Feb 13;11:1136596. doi: 10.3389/fpubh.2023.1136596. eCollection 2023.
9
Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature.卵巢癌的危险因素:文献的伞形综述
Cancers (Basel). 2022 May 30;14(11):2708. doi: 10.3390/cancers14112708.
10
The burden and risks of emerging complications of diabetes mellitus.糖尿病新并发症的负担和风险。
Nat Rev Endocrinol. 2022 Sep;18(9):525-539. doi: 10.1038/s41574-022-00690-7. Epub 2022 Jun 6.